Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P N Durrington

Showing results (71-80 of 189) with videos related to

Pageof 19
Sort By:
QJM : Monthly Journal of the Association of Physicians|February 9, 2002
Costs of aspirin and statins in general practiceA Drummond, S Kwok, J Morgan, et al.
Atherosclerosis|December 1, 1982
The assessment of Achilles tendon size in primary hypercholesterolaemia by computed tomographyP N Durrington, J E Adams, M D Beastall
Lancet (London, England)|April 30, 1994
Suppression of non-esterified fatty acids to treat type A insulin resistance syndromeS Kumar, P N Durrington, D Bhatnagar, et al.
Clinical Science (London, England : 1979)|December 1, 1985
Short-term effects of beta-adrenoceptor blocking drugs with and without cardioselectivity and intrinsic sympathomimetic activity on lipoprotein metabolism in hypertriglyceridaemic patients and in normal menP N Durrington, W C Brownlee, D M Large
Chemico-Biological Interactions|July 27, 1999
Low serum paraoxonase: a risk factor for atherosclerotic disease?M I Mackness, P N Durrington, A Ayub, et al.
Lancet (London, England)|March 22, 1997
Alloenzymes of paraoxonase and effectiveness of high-density lipoproteins in protecting low-density lipoprotein against lipid peroxidationM I Mackness, S Arrol, B Mackness, et al.
Journal of Internal Medicine|November 1, 1990
Elevation of skeletal muscle isoform of serum creatine kinase in heterozygous familial hypercholesterolaemiaD Bhatnagar, P N Durrington, R Neary, et al.
Atherosclerosis|December 1, 1993
Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonaseM I Mackness, S Arrol, C Abbott, et al.
Rheumatology (Oxford, England)|July 18, 2003
Prevention of cardiovascular disease in systemic lupus erythematosus--proposed guidelines for risk factor managementJ Wajed, Y Ahmad, P N Durrington, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 1, 1997
Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-I in the human artery wall with the progression of atherosclerosisB Mackness, R Hunt, P N Durrington, et al.
Pageof 19

Showing results (71-80 of 189) with videos related to

Sort By:
Pageof 19
QJM : Monthly Journal of the Association of Physicians|February 9, 2002
Costs of aspirin and statins in general practiceA Drummond, S Kwok, J Morgan, et al.
Atherosclerosis|December 1, 1982
The assessment of Achilles tendon size in primary hypercholesterolaemia by computed tomographyP N Durrington, J E Adams, M D Beastall
Lancet (London, England)|April 30, 1994
Suppression of non-esterified fatty acids to treat type A insulin resistance syndromeS Kumar, P N Durrington, D Bhatnagar, et al.
Clinical Science (London, England : 1979)|December 1, 1985
Short-term effects of beta-adrenoceptor blocking drugs with and without cardioselectivity and intrinsic sympathomimetic activity on lipoprotein metabolism in hypertriglyceridaemic patients and in normal menP N Durrington, W C Brownlee, D M Large
Chemico-Biological Interactions|July 27, 1999
Low serum paraoxonase: a risk factor for atherosclerotic disease?M I Mackness, P N Durrington, A Ayub, et al.
Lancet (London, England)|March 22, 1997
Alloenzymes of paraoxonase and effectiveness of high-density lipoproteins in protecting low-density lipoprotein against lipid peroxidationM I Mackness, S Arrol, B Mackness, et al.
Journal of Internal Medicine|November 1, 1990
Elevation of skeletal muscle isoform of serum creatine kinase in heterozygous familial hypercholesterolaemiaD Bhatnagar, P N Durrington, R Neary, et al.
Atherosclerosis|December 1, 1993
Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonaseM I Mackness, S Arrol, C Abbott, et al.
Rheumatology (Oxford, England)|July 18, 2003
Prevention of cardiovascular disease in systemic lupus erythematosus--proposed guidelines for risk factor managementJ Wajed, Y Ahmad, P N Durrington, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 1, 1997
Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-I in the human artery wall with the progression of atherosclerosisB Mackness, R Hunt, P N Durrington, et al.
Pageof 19